CoChat

Recombinant Human Leptin in Women With Hypothalamic Amenorrhea

Welt, Corrine K., Chan, Jean L., Bullen, John, Murphy, Robyn, Smith, Patricia, DePaoli, Alex M., Karalis, Aspasia, Mantzoros, Christos S. · 2005 · Obstetrical & Gynecological Survey
Cited by 104

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Hypothalamic amenorrhea, characterized by absent menstrual cycles and low estrogen levels, reportedly accounts for more than 30% of all cases of amenorrhea in women of reproductive age. Infertility and bone loss are possible consequences. Functional hypothalamic amenorrhea occurs when, for any reason, there is a relative energy deficit. Leptin levels are low in these patients, and the normal diurnal variation in leptin levels is absent. To determine whether low leptin levels cause neuroendocrine and reproductive dysfunction, 8 women with hypothalamic amenorrhea resulting from low body weight or strenuous exercise prospectively received recombinant human leptin for 2 to 3 months. Six control women received no treatment. Participants self-administered 0.08 mg/kg of recombinant human leptin subcutaneously each day, 40% of it in the morning and 60% in the evening. Serum leptin levels increased during treatment and body weight decreased slightly. Food intake and resting metabolic rate did not change appreciably. Three of 8 women had an ovulatory menstrual cycle while receiving leptin. Two others had a preovulatory follicle but did not ovulate. Leptin treatment significantly increased maximum follicle diameter, the number of dominant follicles, ovarian volume, and endometrial thickness. Mean levels of luteinizing hormone (LH) increased during treatment, and LH pulse patterns improved or became normal in 6 of 8 women. Thyroid hormone levels increased but remained within the normal range. Markers of bone formation, including bone alkaline phosphatase and osteocalcin, rose significantly during leptin treatment. There was no significant change in urinary N-telopeptides, a marker of bone resorption. Total bone density did not change significantly. No adverse effects were noted. Patients reported decreased appetite but felt well. In this prospective study, leptin treatment of women with hypothalamic amenorrhea normalized reproductive hormone levels, follicle development, and menstrual cyclicity. The findings suggest that leptin, which reflects the adequacy of stored energy, is necessary for normal neuroendocrine and reproductive functioning.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.ogx.0000151645.22134.0b

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 104

Metadata

Authors
Welt, C. K., Chan, J. L., Bullen, J., Murphy, R., Smith, P., DePaoli, A. M., Karalis, A., & Mantzoros, C. S.
Venue
Obstetrical & Gynecological Survey
Published
2005-02
Volume
60
Issue
2
Pages
104-105
ISSN
0029-7828 (ISSN-L)
OpenAlex
W1972586753
Cited by
104
References
1
FWCI
16.28
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Recombinant Human Leptin in Women With Hypothalamic Amenorrhea. https://app.cochat.ai/papers/10.1097/01.ogx.0000151645.22134.0b
The paper
Welt, C. K., Chan, J. L., Bullen, J., Murphy, R., Smith, P., DePaoli, A. M., Karalis, A., & Mantzoros, C. S. (2005). Recombinant Human Leptin in Women With Hypothalamic Amenorrhea. Obstetrical & Gynecological Survey. https://doi.org/10.1097/01.ogx.0000151645.22134.0b

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.